| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66996dcf2dc59f595b8c0584986d50b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
2014-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae27f40a57fda44812b706194db5535b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2fa190802d5054e948000c7a1af0586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335569007a74abfa7f2f6b6ffdc1ccaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10dcebd4fba1a0603d5b9f2f2c658b7b |
| publicationDate |
2014-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140111982-A |
| titleOfInvention |
Complex formulation comprising valsartan and rosuvastatin calcium and method for the preparation thereof |
| abstract |
The present invention relates to a pharmaceutical composition characterized by containing valsartan and rosuvatatin calcium as an active ingredient, and a preparation method thereof. The valsartan and rosuvastatin calcium-containing pharmaceutical composition according to the present invention alleviates side effects of the existing single preparations and improves the compliance of patients with cardiovascular diseases, hyperlipidemia diseases and their multiple diseases, In particular, it has a synergistic effect in the treatment of hypertension, and granules of valsartan and post-mixing of rosuvastatin calcium show an advantage of increasing the dissolution rate of valsartan and rosuvastatin calcium and improving the therapeutic effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016126115-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101875112-B1 |
| priorityDate |
2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |